| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NEUROCRINE BIOSCIE COM USD0.001 | 6,903 | 299,000 | 0.25% | ||
| 2 | VERTEX PHARMACEUTICALS INC | 3,339 | 365,000 | 0.30% | ||
| 3 | ISHARES | 10,000 | 375,000 | 0.31% | Put | |
| 4 | SEATTLE GENETICS INC | 6,433 | 404,000 | 0.34% | ||
| 5 | TESARO INCORPORATED | 2,860 | 440,000 | 0.37% | ||
| 6 | REGENERON PHARMACEUTICALS | 1,179 | 457,000 | 0.38% | ||
| 7 | LILLY ELI & CO | 7,969 | 670,000 | 0.56% | ||
| 8 | ALEXION PHARMACEUTIC | 9,245 | 1,121,000 | 0.93% | ||
| 9 | UNITEDHEALTH GROUP INC | 9,772 | 1,603,000 | 1.33% | ||
| 10 | CELGENE CORP | 14,131 | 1,758,000 | 1.46% | ||
| 11 | BIOMARIN PHARMACEUTICAL INC | 21,624 | 1,898,000 | 1.58% | ||
| 12 | INCYTE CORP | 15,188 | 2,030,000 | 1.69% | ||
| 13 | ISHARES | 100,000 | 3,746,000 | 3.11% | Call | |
| 14 | ANHEUSER BUSCH INBEV SA/NV | 109,700 | 12,041,000 | 10.00% | ||
| 15 | KRAFT HEINZ CO | 506,888 | 46,030,000 | 38.24% | ||
| 16 | SPDR S&P 500 ETF TR | 200,000 | 47,148,000 | 39.16% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-17-000966, filed 2017.05.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
